Life sciences companies run on legacy enterprise systems — ERPs, point solutions, and platforms built two decades ago. These systems are expensive to maintain, difficult to customise, and impossible to extend without deep vendor dependency. Every new market, every new therapy, every new regulation means months of integration work.
We saw an industry spending billions on technology that was actively slowing down its pace of innovation. The answer wasn't another point solution or another layer on top of an ERP. It was a platform — one that gives pharmaceutical companies all the enterprise guardrails they need for security and compliance, but built on open standards, supporting quick development, and embracing every modern technology available.
That's what Zelthy is. A platform-as-a-service for life sciences — where the same infrastructure that keeps you compliant also makes you fast.
Zelthy ships production software for the most regulated industry in the world. Our operating principles reflect that reality.
Anshuman and Kaustubh start Healthlane Technologies with a thesis: life sciences deserves a modern application platform, not more point solutions.
Track-and-trace platform goes live with a top-10 pharma company in India. Validates the platform approach against entrenched point solutions.
Traceability platform scales across multiple manufacturing sites and distribution tiers. Expands to patient services and commercial operations verticals.
Deployments go live across Southeast Asia, ANZ, and Middle East. Platform proves portability across regulatory environments and market structures.
The core framework is released as open source — making the enterprise guardrails available to the broader regulated-industry developer community.
AI agent layer ships across all verticals. Platform now live in 10+ countries with 500+ applications in production serving global pharma companies.
We're always looking for people who want to modernise the most regulated industry in the world. And for companies ready to move faster.